A thermosensitive hydrogel encapsulating 2-DG alleviates periodontitis by inhibiting glycolysis and effector response of Th17 cells

To investigate the mechanism of Th17 cells in immunomodulation during periodontitis and develop a localized drug delivery system based on glycolysis inhibition for safer and more effective therapeutic interventions. Periodontitis models were established via the use of IL17A-KO mice to evaluate the impact of Th17-related cytokine deficiency on pathological progression. Using single-cell RNA sequencing (scRNA-seq), we investigated the metabolic profile of CD4 + T cells under periodontitis conditions. The glycolysis inhibitor 2-deoxy-D-glucose (2-DG) was used to assess its ability to suppress CD4 + T-cell proliferation and Th17 differentiation. A thermosensitive PLGA-PEG-PLGA hydrogel encapsulating 2-DG was synthesized and locally administered to a murine periodontitis model. IL17A-KO mice exhibited significantly attenuated alveolar bone resorption. Single-cell RNA sequencing revealed that, under periodontitis conditions, CD4 + T cells exhibited enhanced differentiation toward Th17 cells and increased glycolysis. The 2-DG hydrogel inhibited CD4 + T-cell expansion and Th17 polarization. Local application of the 2-DG hydrogel reduced periodontal inflammation, decreased bone destruction, and diminished granulocyte infiltration in gingival tissues. Th17-cell differentiation exacerbates periodontitis progression, and glycolysis inhibition effectively modulates Th17-driven immunity. The localized 2-DG hydrogel delivery system presents a promising translational strategy for periodontitis management.

• Publication year

  2026

• Venue

  Frontiers in Pharmacology

• Publication date

  2026-02-25

• Fields of study

  Not labeled

• Identifiers
  DOI 10.3389/fphar.2026.1767931PMCID PMC12975590
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets

  2025cited by this paper
• Local Drug Delivery Systems for Cancer Therapy

  2025cited by this paper
• From complexity to consensus: A roadmap for neutrophil classification.

  2025cited by this paper
• Neutrophil extracellular traps and interleukin-1β in cystic fibrosis lung disease

  2025cited by this paper
• IL-17A drives a fibroblast-neutrophil-NET axis to exacerbate immunopathology in the lung with diffuse alveolar damage

  2025cited by this paper
• Cellular metabolism in Th9, Th17, and Treg cell differentiation

  2025cited by this paper
• γδ+ T-cell-derived IL-17A stimulates airway epithelial/stromal cells to secrete G-CSF, promoting lung-specific pathogenic Siglec-F+ neutrophil development in PPE-induced emphysema

  2025cited by this paper
• Development of Injectable Thermosensitive Nanocomposite Hydrogel for Ratiometric Drug Delivery to Treat Drug Resistant Chondrosarcoma In Vivo.

  2024cited by this paper
• Targeting hexokinase 1 alleviates NLRP3-mediated inflammation in apical periodontitis: a laboratory investigation.

  2023cited by this paper
• Advances in hydrogels for the treatment of periodontitis.

  2023cited by this paper
• TRAF-STOP alleviates osteoclastogenesis in periodontitis

  2023cited by this paper
• The PRAK-NRF2 axis promotes the differentiation of Th17 cells by mediating the redox homeostasis and glycolysis

  2023cited by this paper
• Glycolytic reprogramming controls periodontitis-associated macrophage pyroptosis via AMPK/SIRT1/NF-κB signaling pathway.

  2023cited by this paper
• Correction: Vidal et al. From Messengers to Receptors in Psoriasis: The Role of IL-17RA in Disease and Treatment. Int. J. Mol. Sci. 2021, 22, 6740

  2022cited by this paper
• From Messengers to Receptors in Psoriasis: The Role of IL-17RA in Disease and Treatment

  2021cited by this paper
• IL-17C in human mucosal immunity: More than just a middle child.

  2021cited by this paper
• Development of PLGA-PEG-PLGA Hydrogel Delivery System for Enhanced Immunoreaction and Efficacy of Newcastle Disease Virus DNA Vaccine

  2020cited by this paper
• Current concepts in the management of periodontitis.

  2020cited by this paper
• Niche-selective inhibition of pathogenic Th17 cells by targeting metabolic redundancy

  2019cited by this paper
• Th17 Cells and the IL-23/IL-17 Axis in the Pathogenesis of Periodontitis and Immune-Mediated Inflammatory Diseases

  2019cited by this paper
• A dysbiotic microbiome triggers TH17 cells to mediate oral mucosal immunopathology in mice and humans

  2018cited by this paper
• The spectrum of T cell metabolism in health and disease

  2017cited by this paper
• Genetic, immunological, and clinical features of patients with bacterial and fungal infections due to inherited IL-17RA deficiency

  2016cited by this paper
• Basic biology and role of interleukin-17 in immunity and inflammation.

  2015cited by this paper
• Characterization of the human immune cell network at the gingival barrier

  2015cited by this paper
• Fatty acid metabolism in the regulation of T cell function.

  2015cited by this paper
• Periodontitis: from microbial immune subversion to systemic inflammation

  2014cited by this paper
• IL-17 Receptor A Signaling Is Protective in Infection-Stimulated Periapical Bone Destruction

  2013cited by this paper
• HIF1α–dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells

  2011cited by this paper
• Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier.

  2011cited by this paper
• The Interleukin-17 Receptor Plays a Gender-Dependent Role in Host Protection against Porphyromonas gingivalis-Induced Periodontal Bone Loss

  2008cited by this paper
• An essential role for IL-17 in preventing pathogen-initiated bone destruction: recruitment of neutrophils to inflamed bone requires IL-17 receptor-dependent signals.

  2007cited by this paper
• The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells.

  2006cited by this paper
• A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17

  2005cited by this paper
• Interleukin-17 family members and inflammation.

  2004cited by this paper
• Interleukin-17 family and IL-17 receptors.

  2003cited by this paper

• No citing papers are available for this paper.